A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

Completed · Phase 3 · Has a placebo group

Conditions studied: Asthma

In brief

This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma with an eosinophilic phenotype.

Key facts

Study ID

NCT04718103

Run by

GlaxoSmithKline

People needed

397

Starts

2021-02-04

Expected to finish

2024-04-11

Last updated by the study team

2024-11-29

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Lancaster, California, United States
• GSK Investigational Site — Colorado Springs, Colorado, United States
• GSK Investigational Site — Lafayette, Colorado, United States
• GSK Investigational Site — Aventura, Florida, United States
• GSK Investigational Site — Hialeah, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Miami Lakes, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Atlanta, Georgia, United States
• GSK Investigational Site — Evanston, Illinois, United States
• GSK Investigational Site — Columbia, Maryland, United States
• GSK Investigational Site — Dearborn, Michigan, United States
• GSK Investigational Site — Ypsilanti, Michigan, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — Northfield, New Jersey, United States
• GSK Investigational Site — Toms River, New Jersey, United States
• GSK Investigational Site — The Bronx, New York, United States
• GSK Investigational Site — Huntersville, North Carolina, United States
• GSK Investigational Site — Winston-Salem, North Carolina, United States
• GSK Investigational Site — Cincinnati, Ohio, United States
• GSK Investigational Site — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.